Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123M
-
Number of holders
-
1135
-
Total 13F shares, excl. options
-
97.3M
-
Shares change
-
-4.1M
-
Total reported value, excl. options
-
$15.9B
-
Value change
-
-$602M
-
Put/Call ratio
-
0.66
-
Number of buys
-
465
-
Number of sells
-
-498
-
Price
-
$162.91
Significant Holders of CLOROX CO /DE/ - Common Stock (CLX) as of Q3 2024
1,253 filings reported holding CLX - CLOROX CO /DE/ - Common Stock as of Q3 2024.
CLOROX CO /DE/ - Common Stock (CLX) has 1,135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 97.3M shares
of 123M outstanding shares and own 79.21% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15.4M shares), BlackRock, Inc. (10.8M shares), STATE STREET CORP (8.18M shares), GEODE CAPITAL MANAGEMENT, LLC (3.03M shares), MORGAN STANLEY (2.51M shares), STIFEL FINANCIAL CORP (2.33M shares), CITADEL ADVISORS LLC (2.18M shares), Royal Bank of Canada (2.1M shares), VAN ECK ASSOCIATES CORP (1.49M shares), and ProShare Advisors LLC (1.35M shares).
This table shows the top 1135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.